Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 3/2021

02.09.2020

Effects of clinical depression on left ventricular dysfunction in patients with acute coronary syndrome

verfasst von: Jacob Sama, Dhananjay Vaidya, Monica Mukherjee, Marlene Williams

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Depression is associated with heart failure independent of traditional cardiovascular disease risk factors. Enhanced platelet activation has been suggested as a potential mechanism and has been associated with negative inotropic effects that can affect left ventricular ejection fraction (LVEF). We examined 131 consecutive acute coronary syndrome (ACS) patients to assess whether depression increased the risk for developing LV dysfunction, and to determine the effects of platelet serotonin signaling in this relationship. Major depression was assessed using the Structured Clinical Interview and depressive symptoms were measured using the Beck Depression Inventory (BDI), with BDI ≥ 10 defined as abnormal. LV dysfunction was defined as LVEF ≤ 45%. Platelet serotonin response was measured by serotonin augmented platelet aggregation and platelet serotonin receptor density. Mean age of ACS participants was 59 years, 78.6% male and 74.0% Caucasian. 34.4% of patients had a reduced LVEF ≤ 45% on presentation. Almost half (47.0%) of patients had BDI ≥ 10 and 18.0% had major depressive disorder. Platelet serotonin response was found to be augmented in depressed patients with low LVEF compared to depressed patients with normal LVEF (p < 0.020). However, the presence of LV dysfunction was found to be similar in both depressed (32.3%) and non-depressed (36.2%) patients (p = 0.714). This suggests alternative factors contribute to poor cardiovascular outcomes in depressed patients that are independent of LV function in post ACS patients.
Literatur
1.
Zurück zum Zitat Carney RM, Blumenthal JA, Catellier D et al (2003) Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol 92(11):1277–1281PubMed Carney RM, Blumenthal JA, Catellier D et al (2003) Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol 92(11):1277–1281PubMed
2.
Zurück zum Zitat Carney RM, Rich MW, Freedland KE et al (1988) Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 50:627–733PubMed Carney RM, Rich MW, Freedland KE et al (1988) Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 50:627–733PubMed
3.
Zurück zum Zitat Frasure-Smith N, Lespérance F, Juneau M, Talajic M, Bourassa MG (1999) Gender, depression, and one-year prognosis after myocardial infarction. Psychosom Med 61(1):26–37PubMed Frasure-Smith N, Lespérance F, Juneau M, Talajic M, Bourassa MG (1999) Gender, depression, and one-year prognosis after myocardial infarction. Psychosom Med 61(1):26–37PubMed
4.
Zurück zum Zitat Musselman DL, Evans DL, Nemeroff CB (2003) The relationship of depression to cardiovascular disease. Arch Gen Psychiatry 55:580–592 Musselman DL, Evans DL, Nemeroff CB (2003) The relationship of depression to cardiovascular disease. Arch Gen Psychiatry 55:580–592
5.
Zurück zum Zitat Frasure-Smith N, Lespérance F, Talajic M (1995) Depression and 18-month prognosis after myocardial infarction. Circulation 91:99–1005 Frasure-Smith N, Lespérance F, Talajic M (1995) Depression and 18-month prognosis after myocardial infarction. Circulation 91:99–1005
6.
Zurück zum Zitat Ziegelstein RC (2001) Depression after myocardial infarction. Cardiol Rev 9(1):45–51PubMed Ziegelstein RC (2001) Depression after myocardial infarction. Cardiol Rev 9(1):45–51PubMed
7.
Zurück zum Zitat Carney RM, Freedland KE (2008) Depression in patients with coronary heart disease. Am J Med 121(11):S20–S27PubMed Carney RM, Freedland KE (2008) Depression in patients with coronary heart disease. Am J Med 121(11):S20–S27PubMed
8.
Zurück zum Zitat Thombs BD, De Jonge P, Coyne JC et al (2008) Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA 300:2161–2171PubMed Thombs BD, De Jonge P, Coyne JC et al (2008) Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA 300:2161–2171PubMed
9.
Zurück zum Zitat Lespérance F, Frasure-Smith N, Juneau M, Théroux P (2000) Depression and 1-year prognosis in unstable angina. Arch Intern Med 160:1354–1360PubMed Lespérance F, Frasure-Smith N, Juneau M, Théroux P (2000) Depression and 1-year prognosis in unstable angina. Arch Intern Med 160:1354–1360PubMed
10.
Zurück zum Zitat Shimbo D, Child J, Davidson K et al (2002) Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes. Am J Cardiol 89(3):331–333PubMed Shimbo D, Child J, Davidson K et al (2002) Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes. Am J Cardiol 89(3):331–333PubMed
11.
Zurück zum Zitat Morel-Kopp M, Mclean L, Chen Q et al (2009) The association of depression with platelet activation: evidence for a treatment effect. J Thromb Haemost 7(4):573–581PubMed Morel-Kopp M, Mclean L, Chen Q et al (2009) The association of depression with platelet activation: evidence for a treatment effect. J Thromb Haemost 7(4):573–581PubMed
12.
Zurück zum Zitat Musselman DL, Tomer A, Manatunga AK et al (1996) Exaggerated platelet reactivity in major depression. Am J Psychiatry 153(10):1313–1317PubMed Musselman DL, Tomer A, Manatunga AK et al (1996) Exaggerated platelet reactivity in major depression. Am J Psychiatry 153(10):1313–1317PubMed
13.
Zurück zum Zitat Ziegelstein RC, Parakh K, Sakhuja A, Bhat U (2009) Platelet function in patients with major depression. Intern Med J 39(1):38–43PubMed Ziegelstein RC, Parakh K, Sakhuja A, Bhat U (2009) Platelet function in patients with major depression. Intern Med J 39(1):38–43PubMed
14.
Zurück zum Zitat Zafar MU, Paz-Yepes M, Shimbo D et al (2010) Anxiety is a better predictor of platelet reactivity in coronary artery disease patients than depression. Eur Heart J 31:1573–1582PubMedPubMedCentral Zafar MU, Paz-Yepes M, Shimbo D et al (2010) Anxiety is a better predictor of platelet reactivity in coronary artery disease patients than depression. Eur Heart J 31:1573–1582PubMedPubMedCentral
15.
Zurück zum Zitat Williams MS, Ziegelstein RC, McCann UD, Gould NF, Ashvetiya T, Vaidya D (2019) Platelet serotonin signaling in patients with cardiovascular disease and comorbid depression. Psychosom Med 81:352–362PubMedPubMedCentral Williams MS, Ziegelstein RC, McCann UD, Gould NF, Ashvetiya T, Vaidya D (2019) Platelet serotonin signaling in patients with cardiovascular disease and comorbid depression. Psychosom Med 81:352–362PubMedPubMedCentral
16.
Zurück zum Zitat Fujita S, Takeda Y, Kizawa S et al (2015) Platelet volume indices are associated with systolic and diastolic cardiac dysfunction, and left ventricular hypertrophy. BMC Cardiovasc Disord 15:52PubMedPubMedCentral Fujita S, Takeda Y, Kizawa S et al (2015) Platelet volume indices are associated with systolic and diastolic cardiac dysfunction, and left ventricular hypertrophy. BMC Cardiovasc Disord 15:52PubMedPubMedCentral
17.
Zurück zum Zitat Yazici HU, Poyraz F, Sen N et al (2011) Relationship between mean platelet volume and left ventricular systolic function in patients with metabolic syndrome and ST-elevation myocardial infarction. Clin Investig Med 34:E330 Yazici HU, Poyraz F, Sen N et al (2011) Relationship between mean platelet volume and left ventricular systolic function in patients with metabolic syndrome and ST-elevation myocardial infarction. Clin Investig Med 34:E330
18.
Zurück zum Zitat Jiang W, Boyle SH, Ortel TL et al (2015) Platelet aggregation and mental stress induced myocardial ischemia: results from the Responses of Myocardial Ischemia to Escitalopram Treatment (REMIT) study. Am Heart J 169:496–507PubMed Jiang W, Boyle SH, Ortel TL et al (2015) Platelet aggregation and mental stress induced myocardial ischemia: results from the Responses of Myocardial Ischemia to Escitalopram Treatment (REMIT) study. Am Heart J 169:496–507PubMed
20.
Zurück zum Zitat Miller AL, Dib C, Li L et al (2012) Left ventricular ejection fraction assessment among patients with acute myocardial infarction and its association with hospital quality of care and evidence-based therapy use. Circ Cardiovasc Qual Outcomes 5:662–667PubMed Miller AL, Dib C, Li L et al (2012) Left ventricular ejection fraction assessment among patients with acute myocardial infarction and its association with hospital quality of care and evidence-based therapy use. Circ Cardiovasc Qual Outcomes 5:662–667PubMed
21.
Zurück zum Zitat Parodi G, Antoniucci D (2010) Left ventricular remodeling after primary percutaneous coronary intervention. Am Heart J 160:S11–S15PubMed Parodi G, Antoniucci D (2010) Left ventricular remodeling after primary percutaneous coronary intervention. Am Heart J 160:S11–S15PubMed
22.
Zurück zum Zitat Mendis S, Thygesen K, Kuulasmaa K et al (2011) World Health Organization definition of myocardial infarction: 2008-09 revision. Int J Epidemiol 40:139–146PubMed Mendis S, Thygesen K, Kuulasmaa K et al (2011) World Health Organization definition of myocardial infarction: 2008-09 revision. Int J Epidemiol 40:139–146PubMed
23.
Zurück zum Zitat Yancy CW, Jessup M, Bozkurt B et al (2013) 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American college of cardiology foundation/American Heart Association task force on practice guidelines. Circulation 128:1810–1852PubMed Yancy CW, Jessup M, Bozkurt B et al (2013) 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American college of cardiology foundation/American Heart Association task force on practice guidelines. Circulation 128:1810–1852PubMed
24.
Zurück zum Zitat Hsu JJ, Ziaeian B, Fonarow GC (2017) Heart failure with mid-range (borderline) ejection fraction. JACC Heart Fail 5:763–771PubMedPubMedCentral Hsu JJ, Ziaeian B, Fonarow GC (2017) Heart failure with mid-range (borderline) ejection fraction. JACC Heart Fail 5:763–771PubMedPubMedCentral
25.
Zurück zum Zitat First MB, Spitzer RL, Gibbon M, Williams JBW (2002) Structured clinical interview for DSM-IV axis I disorders, research version, patient edition (SCID-I/P). Biometrics Research, New York State Psychiatric Institude, New York First MB, Spitzer RL, Gibbon M, Williams JBW (2002) Structured clinical interview for DSM-IV axis I disorders, research version, patient edition (SCID-I/P). Biometrics Research, New York State Psychiatric Institude, New York
26.
Zurück zum Zitat Beck AT, Steer RA, Brown GK (1996) Manual for the Beck Depression Inventory-II. TX Psychol Corp, San Antonio Beck AT, Steer RA, Brown GK (1996) Manual for the Beck Depression Inventory-II. TX Psychol Corp, San Antonio
27.
Zurück zum Zitat Arranz B, Rosel P, Sarró S et al (2003) Altered platelet serotonin 5-HT2A receptor density but not second messenger inositol trisphosphate levels in drug-free schizophrenic patients. Psychiatry Res 118:165–174PubMed Arranz B, Rosel P, Sarró S et al (2003) Altered platelet serotonin 5-HT2A receptor density but not second messenger inositol trisphosphate levels in drug-free schizophrenic patients. Psychiatry Res 118:165–174PubMed
28.
Zurück zum Zitat Lv J, Liu F (2017) The role of serotonin beyond the central nervous system during embryogenesis. Front Cell Neurosci 11:74PubMedPubMedCentral Lv J, Liu F (2017) The role of serotonin beyond the central nervous system during embryogenesis. Front Cell Neurosci 11:74PubMedPubMedCentral
29.
Zurück zum Zitat Ayme-Dietrich E, Aubertin-Kirch G, Maroteaux L, Monassier L (2017) Cardiovascular remodeling and the peripheral serotonergic system. Arch Cardiovasc Dis 110(1):51–59PubMed Ayme-Dietrich E, Aubertin-Kirch G, Maroteaux L, Monassier L (2017) Cardiovascular remodeling and the peripheral serotonergic system. Arch Cardiovasc Dis 110(1):51–59PubMed
30.
Zurück zum Zitat Williams MS (2012) Platelets and depression in cardiovascular disease: a brief review of the current literature. World J Psychiatry 2:114–123PubMedPubMedCentral Williams MS (2012) Platelets and depression in cardiovascular disease: a brief review of the current literature. World J Psychiatry 2:114–123PubMedPubMedCentral
31.
Zurück zum Zitat Mendelson SD (2000) The current status of the platelet 5-HT(2A) receptor in depression. J Affect Disord 57:13–24PubMed Mendelson SD (2000) The current status of the platelet 5-HT(2A) receptor in depression. J Affect Disord 57:13–24PubMed
32.
Zurück zum Zitat Hrdina PD, Bakish D, Chudzik J, Ravindran A, Lapierre YD (1995) Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors. J Psychiatry Neurosci 20:11–19PubMedPubMedCentral Hrdina PD, Bakish D, Chudzik J, Ravindran A, Lapierre YD (1995) Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors. J Psychiatry Neurosci 20:11–19PubMedPubMedCentral
33.
Zurück zum Zitat Sheline YI, Bardgett ME, Jackson JL, Newcomer JW, Csernansky JG (1995) Platelet serotonin markers and depressive symptomatology. Biol Psychiatry 37:442–447PubMed Sheline YI, Bardgett ME, Jackson JL, Newcomer JW, Csernansky JG (1995) Platelet serotonin markers and depressive symptomatology. Biol Psychiatry 37:442–447PubMed
34.
Zurück zum Zitat Rao ML, Hawellek B, Papassotiropoulos A, Deister A, Frahnert C (1998) Upregulation of the platelet serotonin(2A) receptor and low blood serotonin in suicidal psychiatric patients. Neuropsychobiology 38:84–89PubMed Rao ML, Hawellek B, Papassotiropoulos A, Deister A, Frahnert C (1998) Upregulation of the platelet serotonin(2A) receptor and low blood serotonin in suicidal psychiatric patients. Neuropsychobiology 38:84–89PubMed
35.
Zurück zum Zitat Berger JS, Becker RC, Kuhn C, Helms MJ, Ortel TL, Williams R (2013) Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation. Thromb Haemost 109:85PubMed Berger JS, Becker RC, Kuhn C, Helms MJ, Ortel TL, Williams R (2013) Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation. Thromb Haemost 109:85PubMed
36.
Zurück zum Zitat Lett H, Ali S, Whooley M (2008) Depression and cardiac function in patients with stable coronary heart disease: findings from the heart and soul study. Psychosom Med 70:444–449PubMedPubMedCentral Lett H, Ali S, Whooley M (2008) Depression and cardiac function in patients with stable coronary heart disease: findings from the heart and soul study. Psychosom Med 70:444–449PubMedPubMedCentral
37.
Zurück zum Zitat Spijkerman TA, Van Den Brink RHS, Jansen JHC, Crijns HJGM, Ormel J (2005) Who is at risk of post-MI depressive symptoms? J Psychosom Res 58(5):425–432PubMed Spijkerman TA, Van Den Brink RHS, Jansen JHC, Crijns HJGM, Ormel J (2005) Who is at risk of post-MI depressive symptoms? J Psychosom Res 58(5):425–432PubMed
38.
Zurück zum Zitat Lespérance F, Frasure-Smith N, Talajic M (1996) Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med 58(2):99–110PubMed Lespérance F, Frasure-Smith N, Talajic M (1996) Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med 58(2):99–110PubMed
39.
Zurück zum Zitat Strik JJMH, Lousberg R, Cheriex EC, Honig A (2004) One year cumulative incidence of depression following myocardial infarction and impact on cardiac outcome. J Psychosom Res 56:59–66PubMed Strik JJMH, Lousberg R, Cheriex EC, Honig A (2004) One year cumulative incidence of depression following myocardial infarction and impact on cardiac outcome. J Psychosom Res 56:59–66PubMed
40.
Zurück zum Zitat Bush DE, Ziegelstein RC, Tayback M et al (2001) Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 88:337–341PubMed Bush DE, Ziegelstein RC, Tayback M et al (2001) Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 88:337–341PubMed
41.
Zurück zum Zitat Kim Y-H, Kim SH, Lim SY et al (2012) Relationship between depression and subclinical left ventricular changes in the general population. Heart 98(18):1378–1383PubMed Kim Y-H, Kim SH, Lim SY et al (2012) Relationship between depression and subclinical left ventricular changes in the general population. Heart 98(18):1378–1383PubMed
42.
Zurück zum Zitat Carney RM, Freedland KE, Veith RC (2005) Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med 67(SUPPL. 1):S29–S33PubMed Carney RM, Freedland KE, Veith RC (2005) Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med 67(SUPPL. 1):S29–S33PubMed
43.
Zurück zum Zitat Kent LK, Shapiro PA (2009) Depression and related psychological factors in heart disease. Harv Rev Psychiatry 17(6):377–388PubMed Kent LK, Shapiro PA (2009) Depression and related psychological factors in heart disease. Harv Rev Psychiatry 17(6):377–388PubMed
44.
Zurück zum Zitat Denollet J, de Jonge P, Kuyper A et al (2009) Depression and type D personality represent different forms of distress in the Myocardial INfarction and Depression—Intervention Trial (MIND-IT). Psychol Med 39(05):749–756PubMed Denollet J, de Jonge P, Kuyper A et al (2009) Depression and type D personality represent different forms of distress in the Myocardial INfarction and Depression—Intervention Trial (MIND-IT). Psychol Med 39(05):749–756PubMed
45.
Zurück zum Zitat Welin C, Lappas G, Wilhelmsen L (2000) Independent importance of psychosocial factors for prognosis after myocardial infarction. J Intern Med 247:629–639PubMed Welin C, Lappas G, Wilhelmsen L (2000) Independent importance of psychosocial factors for prognosis after myocardial infarction. J Intern Med 247:629–639PubMed
Metadaten
Titel
Effects of clinical depression on left ventricular dysfunction in patients with acute coronary syndrome
verfasst von
Jacob Sama
Dhananjay Vaidya
Monica Mukherjee
Marlene Williams
Publikationsdatum
02.09.2020
Verlag
Springer US
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 3/2021
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-020-02268-4

Weitere Artikel der Ausgabe 3/2021

Journal of Thrombosis and Thrombolysis 3/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.